Class I or III Antiarrhythmic Medications
AFI-30
Phase 3 small_molecule completed
Quick answer
Class I or III Antiarrhythmic Medications for Atrial Fibrillation is a Phase 3 program (small_molecule) at Rhythm Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Rhythm Pharmaceuticals Netherlands B.V.
- Indication
- Atrial Fibrillation
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed